EdgarLookup

SOLIGENIX, INC. — SC 13G/A Filings

36 SC 13G/A filings on record

This page lists all SC 13G/A filings submitted to the SEC by SOLIGENIX, INC. (SNGX), sorted by most recent first. Each row links to the full filing on EdgarLookup. SOLIGENIX, INC. has filed 36 SC 13G/A documents with the SEC since 2007. To view all SEC filings by SOLIGENIX, INC., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 10KSB 10KSB/A 10QSB 10QSB/A 25-NSE 3 3/A 4 4/A 424B3 424B4 424B5 425 8-A12B 8-A12B/A 8-A12G 8-K 8-K/A ARS AW CERTNAS CORRESP CT ORDER D DEF 14A DEFA14A DEFC14A DEFR14A DRS EFFECT NT 10-K NT 10-Q POS AM PRE 14A PRE 14C PREC14A PREN14A PRER14A REGDEX S-1 S-1/A S-1MEF S-2 S-2/A S-3 S-3/A S-4 S-4/A S-8 SB-2 SB-2/A SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13G SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
SC 13G/A SC 13G/A 0001193125-20-134872 May 6, 2020
SC 13G/A SC 13G/A 0001193125-20-117150 Apr 23, 2020
SC 13G/A SC 13G/A 0001104659-20-012480 Feb 7, 2020
SC 13G/A SC 13G/A 0001104659-19-007980 Feb 13, 2019
SC 13G/A SC 13G/A 0001104659-18-048060 Jul 30, 2018
SC 13G/A SC 13G/A 0001104659-18-008949 Feb 13, 2018
SC 13G/A SC 13G/A 0001019056-18-000316 Feb 13, 2018
SC 13G/A BAM OPPORTUNITY FUND, LLC SCHEDULE 13GA 0000950159-12-000040 Jan 30, 2012
SC 13G/A SCHEDULE 13G AMENDMENT - SOLIGENIX, INC. 0000929638-11-000051 Jan 13, 2011
SC 13G/A 0000929638-10-000567 Aug 20, 2010
SC 13G/A 0000929638-10-000360 May 18, 2010
SC 13G/A 0000929638-10-000181 Feb 19, 2010
SC 13G/A 0000929638-10-000021 Jan 12, 2010
SC 13G/A SCHEDULE 13GA 0001009448-09-000084 Nov 12, 2009
SC 13G/A SCHEDULE 13G/A 0001362310-08-000908 Feb 14, 2008
SC 13G/A DOR BIOPHARM SIGMA TAU INTERNATIONAL S.A. SCHEDULE 13G/A NO. 1 0000950162-08-000100 Feb 14, 2008
SC 13G/A 0000919574-08-001085 Feb 14, 2008
SC 13G/A DOR BIOPHARMA INC. - SIGMA TAU PHARMACEUTICALS SCHEDULE 13G/A NO. 1 0000950162-08-000097 Feb 13, 2008
SC 13G/A DOR BIOPHARMA INC. SIGMA TAU AMERICA SCHEDULE 13G/A NO. 1 0000950162-08-000096 Feb 13, 2008
SC 13G/A DOR BIOPHARMA INC./SIGMA TAU FINANZIARIA SCHEDULE 13G/A NO. 1 0000950162-08-000095 Feb 13, 2008
SC 13G/A DOR BIOPHARMA, INC./CLAUDIO CAVAZZA SCHEDULE 13G/A NO. 1 0000950162-08-000094 Feb 13, 2008
SC 13G/A DOR BIOPHARMA, INC./PAOLO CAVAZZA SCHEDULE 13G/A NO. 1 0000950162-08-000093 Feb 13, 2008
SC 13G/A AMENDMENT TO SCHEDULE 13G 0000950134-07-012509 May 29, 2007
SC 13G/A 0000919574-07-000891 Feb 14, 2007
SC 13G/A 0000919574-07-000514 Feb 9, 2007
SC 13G/A 0000919574-06-001255 Feb 14, 2006
SC 13G/A ROTH-STARK FILINGS\2006\FEB 13GA-DOR BIOPHARMA 0000950138-06-000108 Feb 14, 2006
SC 13G/A 0000919574-05-001313 Mar 21, 2005
SC 13G/A AMENDED SCHEDULE 13G 0000950116-05-000757 Feb 24, 2005
SC 13G/A /DOCS AND PROJECTS/ROTH STARK/2005 FILINGS/ 0000950138-05-000172 Feb 15, 2005
SC 13G/A ROTH-STARK\2005\FEB 13GAS\FEB 13GA-DOR BIOPHARMA 0000950138-05-000144 Feb 14, 2005
SC 13G/A FORM 13G HOLDINGS REPORT 0001172661-05-000083 Feb 14, 2005
SC 13G/A SC 13G/A 0000950116-05-000519 Feb 10, 2005
SC 13G/A AMENDMENT NO. 1 0000947871-04-000532 Feb 20, 2004
SC 13G/A AMENDMENT NO. 1 0000947871-04-000530 Feb 20, 2004
SC 13G/A AMENDMENT NO. 1 0000947871-04-000528 Feb 20, 2004